Cost and Effectiveness of Lung Cancer Screening in Poland: a 15-year projection
Lung cancer is the leading cause of cancer death among men and women in Poland, with about 21,000 deaths annually. Lung cancer screening (LCS) of high-risk populations has been demonstrated to save lives by shifting diagnosis to earlier stages, where there is a higher cure rate. Little analysis has been published on the potential impacts of LCS on the Polish population. This paper discusses a 15-year projection of the high-risk Polish population associated with smoking history, using the framework of a previously published model. Sections include:
- Introduction
- Methods
- Model
- Key parameters and assumptions evaluation
- Model outcomes
- Cost analysis
Explore more tags from this article
About the Author(s)
Contact us
We’re here to help you break through complex challenges and achieve next-level success.
Contact us
We’re here to help you break through complex challenges and achieve next-level success.
Cost and Effectiveness of Lung Cancer Screening in Poland: a 15-year projection
Lung cancer screening programs yield substantial improvements in outcomes, with our analysis estimating an increase of 3.74 life years per cancer case in Poland.